Why commercialization of gene therapy stalled; examining the life cycles of gene therapy technologies
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Why commercialization of gene therapy stalled; examining the life cycles of gene therapy technologies
Authors
Keywords
-
Journal
GENE THERAPY
Volume 21, Issue 2, Pages 188-194
Publisher
Springer Nature
Online
2013-12-05
DOI
10.1038/gt.2013.72
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Gene therapy enters the pharma market: The short story of a long journey
- (2013) Hildegard Büning EMBO Molecular Medicine
- History of gene therapy
- (2013) Thomas Wirth et al. GENE
- Gene therapy clinical trials worldwide to 2012 - an update
- (2013) Samantha L. Ginn et al. JOURNAL OF GENE MEDICINE
- Systematic identification of allosteric protein-metabolite interactions that control enzyme activity in vivo
- (2013) Hannes Link et al. NATURE BIOTECHNOLOGY
- Three-Year Follow-up after Unilateral Subretinal Delivery of Adeno-Associated Virus in Patients with Leber Congenital Amaurosis Type 2
- (2013) Francesco Testa et al. OPHTHALMOLOGY
- Advancing Translational Research Through the NHLBI Gene Therapy Resource Program (GTRP)
- (2013) Cheryl L. McDonald et al. Human Gene Therapy Clinical Development
- Effects of administration of two growth hormone–releasing hormone plasmids to gilts on sow and litter performance for the subsequent three gestations
- (2012) Patricia A. Brown et al. AMERICAN JOURNAL OF VETERINARY RESEARCH
- Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trial
- (2012) D Gaudet et al. GENE THERAPY
- Europe gives gene therapy the green light
- (2012) Karl Gruber LANCET
- Marketed therapeutic antibodies compendium
- (2012) Janice M. Reichert mAbs
- Patterns of technological innovation in biotech
- (2012) Laura M McNamee et al. NATURE BIOTECHNOLOGY
- Safety and efficacy of a xenogeneic DNA vaccine encoding for human tyrosinase as adjunctive treatment for oral malignant melanoma in dogs following surgical excision of the primary tumor
- (2011) Deborah A. Grosenbaugh et al. AMERICAN JOURNAL OF VETERINARY RESEARCH
- Gene therapy finds its niche
- (2011) Cormac Sheridan NATURE BIOTECHNOLOGY
- Adenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia B
- (2011) Amit C. Nathwani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of Three Vaccines in Protecting Western Scrub-Jays (Aphelocoma californica) from Experimental Infection with West Nile Virus: Implications for Vaccination of Island Scrub-Jays (Aphelocoma insularis)
- (2011) Sarah S. Wheeler et al. VECTOR-BORNE AND ZOONOTIC DISEASES
- Efficacy of Gene Therapy for X-Linked Severe Combined Immunodeficiency
- (2010) Salima Hacein-Bey-Abina et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trends in biotech literature 2008
- (2009) Andrew Marshall NATURE BIOTECHNOLOGY
- Can literature analysis identify innovation drivers in drug discovery?
- (2009) Pankaj Agarwal et al. NATURE REVIEWS DRUG DISCOVERY
- A Comeback for Gene Therapy
- (2009) L. Naldini SCIENCE
- Trends in biotech literature 2007
- (2008) Gaspar Taroncher-Oldenburg et al. NATURE BIOTECHNOLOGY
- Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
- (2008) Albert M. Maguire et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Gene Therapy on Visual Function in Leber's Congenital Amaurosis
- (2008) James W.B. Bainbridge et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started